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ABSTRACT
In this study we describe a novel method to investi-
gate the RNA–RNA interactions between a small
RNA and its target that we termed ‘RNA walk’.
The method is based on UV-induced AMT cross-
linking in vivo followed by affinity selection of the
hybrid molecules and mapping the intermolecular
adducts by RT–PCR or real-time PCR. Domains
carrying the cross-linked adducts fail to efficiently
amplify by PCR compared with non-cross-linked
domains. This method was calibrated and used to
study the interaction between a special tRNA-like
molecule (sRNA-85) that is part of the trypanosome
signal recognition particle (SRP) complex and the
ribosome. Four contact sites between sRNA-85
and rRNA were identified by ‘RNA walk’ and were
further fine-mapped by primer extension. Two of
the contact sites are expected; one contact site
mimics the interaction of the mammalian Alu
domain of SRP with the ribosome and the other
contact sites include a canonical tRNA interaction.
The two other cross-linked sites could not be pre-
dicted. We propose that ‘RNA walk, is a generic
method to map target RNA small RNAs interactions
in vivo.
INTRODUCTION
Small non-coding RNAs (ncRNAs) have recently come to
the center stage of eukaryotic biology, since it was realized
that in most organisms a large amount of genetic infor-
mation is dedicated to the synthesis of RNA molecules
that do not code for proteins. ncRNAs exhibit a range
of diverse functions, including ribosomal RNA matura-
tion (small nucleolar RNAs or snoRNAs), splicing
of pre-mRNA (small nuclear RNAs or snRNAs), DNA
replication (telomerase RNA), protein translocation (7SL
RNA) and gene silencing (microRNAs or miRNAs and
small interfering RNAs or siRNAs). It has been suggested
that ncRNAs are major determinants of the complexity of
an organism, complementing the protein-based regulation
(1,2). Another large group of regulatory RNAs, found
only in recent years in eukaryotes, are the miRNAs and
siRNAs; with a length of only 21 nucleotides; these RNAs
constitute the smallest class of ncRNAs described to date.
miRNAs mostly suppress translation via non-perfect
pairing with the target 30 UTR sequences of mRNAs
(but can also elicit degradation of the target mRNA)
and are central to a wide range of developmental and
physiological processes in metazoa (3).
In the last couple of years, thousands of ncRNAs were
described from bacteria to man based on tiling arrays,
comparative genomics and more recently, deep sequencing
(1,2,4). In some cases bioinformatic approaches suggest
that these small RNAs interact with an RNA target to
regulate their stability or translability. In the case of
microRNAs it was demonstrated that target mRNAs
can either interact with the same microRNA in diﬀerent
domains or the 30UTR is bound by diﬀerent microRNAs
(3). Experimental methods are in demand to examine the
validity of proposed small RNA–target interactions as
well as to map on the target RNA the binding sites
of the small RNA.
Trypanosomes are protozoan parasites whose gene
expression is mediated by RNA-dependent processes.
These organisms lack promoters for protein coding
genes and regulate gene expression by post-transcriptional
processes such as trans-splicing, RNA editing, mRNA
stability and translation (5). Trypanosomes also possess
a very unique signal recognition particle (SRP) that,
similar to eukaryotes, functions in protein translocation
across the ER (6–8). In eukaryotes, binding of the SRP
leads to retardation of peptide elongation, known as elon-
gation arrest (9–11). The SRP–ribosome-nascent chain
complex (RNC) is then targeted to the ER membrane in
a GTP-dependent manner (12). After docking to the
membrane, the RNC is translocated to the translocon.
Binding of the RNC to the translocon leads to insertion
of the nascent chain into the channel; translation then
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(13–15). In mammals the SRP is composed of a single
RNA molecule, 7SL RNA and six proteins; the complex
is divided into two distinct domains, the Alu domain on
one side and the S domain at the opposite end. The Alu
domain is responsible for the elongation arrest activity of
the SRP (16,17). One of the intriguing questions in under-
standing the role of the SRP in protein translocation is
elucidating how the SRP induces transient translational
arrest upon its binding to the ribosome. A detailed
cryo-electron microscopy (EM) study identiﬁed three
interactions of the mammalian S domain with the
ribosome, found in the vicinity of the peptide exit site.
On the other hand, the Alu domain bridges, in a tight
ﬁt, the 6A ˚ space between the large and the small
ribosomal subunits and directly contacts the ribosome
(18). Although the Alu domain is essential for the elonga-
tion arrest function of the mammalian SRP, not all SRPs
in nature carry an Alu domain; notably, the bacterial and
archeal SRPs lack this domain (19,20).
The trypanosome system may represent a unique
solution for the arrest function. The trypanosome SRP
is diﬀerent from all other SRPs described so far in that
it is composed of two RNA molecules, the 7SL RNA and
a unique tRNA-like molecule, sRNA-76 in Trypanosoma
brucei and sRNA-85 in Leptomonas collosoma (6,21).
Structurally, the trypanosome 7SL RNA homolog
resembles the mammalian 7SL RNA except for its Alu
domain (22,23). The trypanosome SRP also lacks the
Alu domain binding proteins (7). We therefore proposed
that the tRNA-like molecule may functionally replace the
missing Alu domain and mediate the arrest function of
trypanosome SRP (6,7). sRNA-85 was shown to interact
with the 7SL RNA by base pairing (6). The association of
sRNA-85 and 7SL RNA was also demonstrated by co-
aﬃnity selection, and AMT cross-linking. sRNA-85
exists together with 7SL RNA in a  14S complex and
this complex transiently associates with the ribosome (6).
Since there is currently no functional in vitro protein
translation/translocation system in trypanosomes, we
could not study the interaction of sRNA-85 with the
ribosome during the translocation cycle in vitro. We there-
fore developed a novel approach termed ‘RNA walk’ to
follow the interaction of this unique molecule with the
ribosome in vivo. ‘RNA walk’ is a generic method that
can be applied to study small RNA–target interactions
in vivo and in vitro. The approach utilizes AMT-induced
UV cross-linking, which links two RNA molecules that
are located in close proximity. The cross-linked species
are mapped by ‘walking’ on the RNA using reverse tran-
scription polymerase chain reaction (RT–PCR) and
primers spanning the region of interest, identifying
domains that cannot be copied eﬃciently due to the
presence of cross-linked adducts. Using this method, we
suggest that sRNA-85 contacts the ribosome in at least
four sites. The four cross-linked sites were ﬁne mapped
by primer extension and oligonucleotide-mediated
RNase H cleavage. Of special interest is the one site
within helix 95, the sarcin ricin loop (SRL) domain,
which was shown to bind the mammalian SRP Alu
domain. Another site reveals a tRNA-like interaction
with the ribosomal P site, the third contact site is
located within the peptidyl-transferase center (PTC) and
the fourth site is within helix 63 of the large subunit. We
propose that in trypanosomes, sRNA-85 may provide a
novel solution for the SRP arrest function in the absence
of a functional Alu domain. This study demonstrates how
the ‘RNA walk’ method made it possible to unravel a
complex interaction between a small RNA and its target
that could not otherwise be solved.
MATERIALS AND METHODS
UV cross-linking of living cells treated with AMT
Cross-linking was performed essentially as described in
Liu et al., 2003 (6). Brieﬂy, L. collosoma cells were har-
vested at 5 10
7cellsml
 1 and washed twice with PBS.
Cells (5 10
9) were concentrated and incubated on ice.
40-Aminomethyl-trioxsalen hydrochloride (AMT)
(Sigma) was added to the cells at a concentration of
0.2mgml
 1. Cells treated with AMT were kept on ice
and irradiated using a UV lamp at 365nm with an inten-
sity of 10milliWattscm
–2 for 60min. Next, the cells were
washed once with PBS and deproteinized by digestion
with proteinase K (Roche) (200mgml
 1 in 1% SDS for
60min). RNA was prepared using TRIzol reagent
(Sigma). For reversal of the cross-linking, the RNA was
irradiated at 254nm UV in the same intensity described
above, for 10min.
Aﬃnity puriﬁcation of sRNA-85 using 20-O-methyl
biotinylated oligonucleotide
Five hundred micrograms of total RNA in hybridization
buﬀer (20mM HEPES pH 8, 5mM MgCl2, 300mM KCl,
0.01% NP40, 1mM DTT) was heated for 2min at 80 C
and put on ice. Oligonucleotide 85-R-1 (wild-type) or
oligonucleotide s85-mutant bio (mutant) (speciﬁed in S1)
(8mg) was added and the solution was incubated overnight
at room temperature. Next, 50ml of blocked Neutravidin
Sepharose beads (Pierce) were added and the reaction was
incubated for 2h at 4 C. Blocking of the beads was in 1ml
blocking buﬀer (700ml DEPC, 200ml WB100 [20mM
HEPES pH 8, 10mM MgCl2, 100mM KCl, 0.01%
NP40, 1mM DTT), 50ml BSA (10mgml
 1), 10ml
Glycogen (20mgml
 1), 40ml tRNA (11mgml
 1). After
binding of the RNA to the oligonucleotide-bound beads,
the beads were washed ﬁve times in WB400 buﬀer (20mM
HEPES pH 8, 10mM MgCl2, 400mM KCl, 0.01% NP40,
1mM DTT). RNA was extracted from the beads
using TRIzol reagent (Sigma) and analyzed by primer
extension (24).
Primer extension and sequencing
Primer extension was performed as described previously
(24). Total RNA, or aﬃnity-selected RNA obtained from
cells treated with AMT and UV cross-linked and
untreated cells, were subjected to primer extension
reaction with [g-
32P]-ATP-labeled oligonucleotides. The
reaction was analyzed on 6% polyacrylamide denaturing
gel next to DNA sequencing reactions performed using the
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plasmids containing the Trypanosoma brucei rRNA
genes. These regions are 100% conserved between
T. brucei and L. major. The secondary structure of
L. major rRNA that is more closely related to L. collosoma
was used. No changes in the DNA sequences presented
next to the primer extension were observed between
L. major and T. brucei and only minor changes were
found outside these domains.
RT–PCR
The RNA was treated with ‘DNA-free’ reagent (Ambion)
according to the manufacturer’s protocol for 30min to
remove DNA contamination. Reverse transcription was
performed on RNA (1/10 of the aﬃnity-selected RNA)
by random priming (Reverse Transcription System,
Promega). The samples were heated for 5min at 70 C,
followed by chilling on ice for 5min. Next, 1U of
AMV-reverse transcriptase (Promega) was added,
together with 1U RNase inhibitor (Promega) and the
elongation reaction was performed according the manu-
facturer’s instructions at 25 C for 10min and then at 50 C
for 60min (Promega kit). The cDNA was used for PCR
ampliﬁcation using primers as speciﬁed in S1. The cDNA
was diluted 1:10, 1:100 and 1:1000 for each primer set, to
determine the dilution that produces PCR in the exponen-
tial phase. For most of the analysis we found that 1:500
dilution of cDNA was in the exponential phase and
resulted in detectable amounts of the PCR products. As
a negative control PCR was performed using primers for
snoRNA (sno-2), an RNA not expected to interact with
sRNA-85 (25). PCR was performed on 1ml of cDNA
(diluted 1:500), 1mM primers and ReadyMix
TMTaq
PCR Reaction Mix with MgCl2 (Sigma). The PCR
conditions were as follows: 95 C for 2min followed by
25 cycles of 95 C for 30s, 60 C for 30s and 72 C for 30s.
Real-time PCR
Real-time PCR was performed in a two-step reaction.
First cDNA was prepared from either 2mg of total RNA
or 1/10 of the aﬃnity-selected RNA (from 500mg
total RNA as starting material) using random primer
and the RevertAid
TMFirst Strand cDNA synthesis kit
(Fermentas) according to the manufacturer’s instructions.
Next, real-time PCR was performed using 1ml of cDNA
described above, diluted 1:100000, 1mM primers and
Absolute Blue QPCR SYBR Green ROX mix (Thermo
Scientiﬁc). The PCR conditions were as follows: 95 C for
2min followed by 40 cycles of 95 C for 30s, 60 C for 30s
and 72 C for 30s. A calibration curve was established
using a PCR product produced with the same primers
examined by the RT–PCR. The fragment was puriﬁed
by QIAquick PCR puriﬁcation kit (Qiagen) and its con-
centration was determined by NanoDrop ND-1000
spectrophotometer (Thermo). Calibration curves were
prepared for each of the domains examined.
Plasmid construction and transformation
The sRNA-85 mutant was generated by PCR mutagenesis
using a primer carrying the mutation and oligonucleotides
situated upstream and downstream of the gene. The
diﬀerent oligonucleotides used for the PCR ampliﬁca-
tion are listed in S1. The mutated sRNA-85 gene was
subcloned into the BamHI site of the pX-neo expression
vector. The mutation was conﬁrmed by DNA sequencing.
Stable cell lines carrying the mutated genes were estab-
lished as described previously (26).
Splint labeling
Ten to twenty micrograms of RNA was mixed with
150pmol of oligonucleotide (see S1 for primer sequence)
and heated for 2min at 85 C in 50mM Tris–HCl (pH 7.8),
10mM MgCl2 and 1mM DTT. The annealing reaction
was quenched on ice for 30min, 50mCi of [a-
32P]-dCTP
(3000Ci/mmol) and 5 units of T7 DNA polymerase
(Sequenase v. 2.0, USB) were added, and the reaction
was incubated for 1h at 37 C. RNA was separated on a
6% polyacrylamide–7M urea gel.
RNase H cleavage
RNase H cleavage of rRNA was performed by annealing
200pmol of oligonucleotides as indicated in ﬁgures
(see S1 for speciﬁc primer sequences) with 20mg of total
RNA at 65 C for 10min in 75mM KCl, 50mM Tris–HCl
(pH 8.3), 3mM MgCl2 and 10mM DTT. The samples
were then placed on ice and two units of RNase H
(NEB) were added. The samples were further incubated
at 37 C for 60min, phenol/chloroform extracted
and ethanol precipitated. Samples were then labeled by
splint labeling (see above) and separated on a 6%
polyacrylamide–7 M urea gel.
Extract preparation and fractionation on sucrose
gradients and northern analysis
Leptomonas collosoma growth and extract preparation
were as previously described (24). Cells were disrupted
using nitrogen cavitation, and RNPs were extracted at
0.1MKCl. The low-salt extracts were layered on continu-
ous 10–30% sucrose gradients containing 100mM KCl.
Gradients were centrifuged at 4 C for either 3 or 22h at
35000 rpm using a Beckman SW41 rotor. RNA prepared
from the sucrose gradient fractions was subjected to
northern analysis.
RESULTS
In vivo cross-linking with AMT and aﬃnity selection
of sRNA-85
In the absence of an in vitro translation–translocation
system in trypanosomes, it is not possible to elucidate
the function of sRNA-85 in vitro. We therefore sought
to elucidate the function of this molecule by mapping its
interaction with the ribosome in vivo. We propose that
sRNA-85 may functionally replace the missing Alu
domain of the trypanosome SRP.
To investigate this complex system, we made use of the
methodology of AMT treatment followed by UV cross-
linking. AMT compounds are unique in their ability to
freeze helical regions of nucleic acids. First, the planar
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region; upon irradiation at 365nm, covalent adducts
form with pyrimidine bases (27). The covalent linkage
can be reversed by irradiation at 254nm. This methodol-
ogy was widely used to study RNA and DNA structures
(28,29). This method was also used in vivo in trypano-
somes to identify interactions between the spliced
leader RNA (SL RNA) and other small RNAs (30).
AMT intercalates within stems formed either inter or
intramolecularly. To identify interactions on the target
due to interactions with small RNA and to avoid
mapping intramolecular interactions that are more
abundant on the target, we had to devise a protocol to
enrich the cross-linked adducts that result from
intermolecular cross-linking. To achieve this goal, we
aﬃnity puriﬁed sRNA-85 together with its covalently
attached rRNA target and compared the adducts on the
rRNA enriched with sRNA-85 to those on total RNA
obtained from the same sample. Only adducts that were
enriched by the aﬃnity selection were considered to be
adducts emerging from the interaction between sRNA-
85 and rRNA. To calibrate the cross-linking in our exper-
imental set-up, we repeated the experiment using the
conditions previously reported for T. brucei (30), and
followed the SL RNA cross-linked species by northern
hybridization (data not shown). The same conditions
were then tested on L. collosoma cells; we ﬁrst performed
a time course of irradiation at 10milliWattscm
 2 from 15
to 60min, and found that 60min of irradiation was
optimal for capturing the cross-linked SL RNA species
(data not shown). We then conﬁrmed that the cross-
linking procedure did not aﬀect our ability to aﬃnity
select sRNA-85. Total RNA was subjected to aﬃnity
selection with 20-O-methyl biotinylated oligonucleotide
complementary to the 30-end of sRNA-85. After elution,
the RNA was subjected to primer extension to detect the
presence of sRNA-85 and tRNA
Arg, which was used to
control for the speciﬁcity of the selection. As can be seen
in Figure 1A, and based on the amount of RNA examined
(see details in the ﬁgure legend), 20% of sRNA-85 was
selected using this procedure. No tRNA
Arg was selected,
conﬁrming the speciﬁcity of the selection (Figure 1A;
lanes 3 and 4). Results (Figure 1B) show little diﬀerence
in the yield of aﬃnity selection using cross-linked
RNA compared with RNA extracted from untreated
cells, suggesting that the cross-linking did not interfere
with the ability to aﬃnity select sRNA-85 from the
irradiated cells.
We next quantiﬁed the procedure of aﬃnity selection
with respect to the enrichment of sRNA-85 and the
levels of rRNA and snoRNA (negative control). To
quantify, sRNA-85 primer extension was used, and the
level of sRNA-85 was calculated based on a calibration
curve generated from picomoles of labeled primers. The
results indicate that 500mg of total RNA contains
 0.2pmol of sRNA-85. After aﬃnity selection we
selected  0.04pmol of this RNA. The same amount
of total RNA contains  30pmol of rRNA based on the
percentage of rRNA in total RNA and that the amount
of mRNA (present at 0.1%) in 10mg of total RNA
is 0.6fmol. Because only 0.1% of RNA was selected
(Figure 1C) only 0.03pmol of rRNA was recovered.
Although this is a rough estimation the calculations
suggest the enrichment of sRNA-85 and the relative low
level of rRNA in the sample.
Since the presence of rRNA contamination can interfere
with mapping the intermolecular adducts, we examined
the contamination of rRNA in the aﬃnity-selected
sRNA-85 preparation. The results (Figure 1C) suggest
that if we perform two rounds of aﬃnity selection we
obtain preparations which are highly enriched for
sRNA-85 (compare lanes 1–3) and carry less of the
contaminating rRNA (compare lanes 4–6). However,
after a single round of aﬃnity selection we lost  90% of
the rRNA and after two rounds of selection rRNA con-
tamination was hardly detected ( 0.1% of the initial
amount). The speciﬁcity of the selection and contamina-
tion was also examined by the level of sno-2 (25).
snoRNAs involved in methylation bind to rRNA during
Figure 1. Aﬃnity selection of sRNA-85 in untreated and AMT UV
crossed-linked cells. (A) Total RNA was prepared from L. collosoma
cells (5 10
9) and subjected to aﬃnity selection using 20-O-methyl
biotinylated oligonucleotide of sRNA-85 as described in ‘Materials
and Methods’ section. The aﬃnity-selected product (‘aﬃnity’) and
10% of the total RNA (T) was subjected to primer extension with
radiolabeled oligonucleotides complementary to sRNA-85 (lanes 1
and 2) or tRNA
Arg (lanes 3 and 4) and separated on a 6% denaturating
gel. (B) Cells were treated with 0.2mgml 
1 AMT, and irradiated at
365nm with UV light (10milliWattscm
 2) for 60min. RNA from the
same number of irradiated (+; lane 2) or untreated ( ; lane 1) cells
was subjected to primer extension and separated on a 6% denaturing
gel. (C) Total RNA from irradiated cells was subjected to either one
round (lanes 2 and 5) or two rounds (lanes 3 and 6) of aﬃnity selection
and primer extension was preformed with oligonucleotides speciﬁc
to sRNA-85 and srRNA-2, and compared with 10% of the total
RNA used for selection (lanes 1 and 4). (D) RNA was prepared
from irradiated cells and from control untreated cells as described
above. The RNA (from 10
10 cells) was subjected to aﬃnity selection
as described in ‘Materials and Methods’ section. The aﬃnity-selected
products (lanes 2 and 3) and 2 mg total RNA (lane 1) were subjected
to reverse transcription using random primers. The cDNA was
ampliﬁed by PCR using primers for snoRNA-2. The PCR products
were separated on 1.5% agarose gel and detected by ethidium
bromide staining.
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extracted from cytoplasmic ribosomes. Indeed, snoRNA-
2 can easily be detected by RT–PCR in total RNA but
cannot be detected in RNA prepared from cells treated
with AMT and UV and after aﬃnity selection with
sRNA-85 oligonucleotide (Figure 1D; compare lanes 1–3).
‘RNA walk’ identiﬁes four potential contact sites
between sRNA-85 and rRNA
To map the potential contact sites between sRNA-85 and
rRNA we developed a novel method that we termed
‘RNA walk’, and is illustrated in Figure 2A. The
method utilizes the in vivo cross-linking described above
and is based on the fact that upon cross-linking the
adducts formed between the target and small RNA will
not allow the reverse transcriptase to copy the cross-linked
region. In the next step, the entire target can be scanned
for the presence of such adducts by simply amplifying
small portions of the cDNA by PCR. Such an experiment
is illustrated in Figure 2B. Brieﬂy, total RNA from
irradiated cells (500mg) and from control untreated cells
were subjected to sRNA-85 aﬃnity selection, and cDNA
was produced from the aﬃnity-selected RNA using
random primers. We performed a calibration curve to
examine at which dilution the ampliﬁcation is exponential
as described in ‘Materials and Methods’ section. Next,
PCR analysis was performed on the cDNA (diluted
Figure 2. Identiﬁcation of the regions where the rRNA interacts with sRNA-85 by the ‘RNA walk’ method. (A) Schematic representation of the
‘RNA walk’ approach. Cells were treated with AMT and subjected to UV irradiation; RNA was then prepared by deproteinization and Trizol
reagent extraction. RNA was then subjected to aﬃnity selection with anti-sense biotinylated oligonucleotide complementary to sRNA-85. cDNA was
prepared from the aﬃnity-selected RNA, and ampliﬁed by PCR using primers covering the entire rRNA target. (B) PCR analyses of cDNA covering
the rRNA. RNA was prepared from irradiated cells and from control untreated cells as described in Figure 1. The RNA (from 10
10 cells) was
subjected to aﬃnity selection as described in ‘Materials and Methods’ section. The aﬃnity-selected product was subjected to reverse transcription
using random primers. The cDNA was ampliﬁed by PCR using primers dividing the rRNA into 12  500nt domains spanning the entire rRNA. The
PCR products were separated on 1.5% agarose gel and detected by ethidium bromide staining. RNA from irradiated and untreated cells is
designated by (+) and ( ), respectively. The positions of the PCR domains are marked by double-headed arrows on the rRNA subunits (indicated).
Stars mark the domains carrying the cross-linked adducts. (C) ‘RNA Walk’ using an internal control. ‘RNA walk’ was performed with aﬃnity-
selected RNA prepared from irradiated cells (+UV) or non-irradiated cells ( UV). The RNA was spiked with 100ng of synthetic RNA (in vitro
transcribed luciferase). cDNA was prepared as described in (B) and PCR was performed using primers that amplify the rRNA domain (listed above
the lanes) and luciferase mRNA in the same reaction. (D) Photoreversal of cross-linking eliminates the block of reverse transcriptase and enables
PCR ampliﬁcation of the cDNA. cDNA was prepared from aﬃnity-selected RNA derived from irradiated cells (lane 2), from untreated cells (lane 1)
and from aﬃnity-selected RNA that was photo reversed (lanes 3 and 4). PCR ampliﬁcation was performed with primers speciﬁc to domain 12.
(E) RNA walk requires both UV and AMT. cDNA was prepared with random primers from aﬃnity-selected RNA derived from untreated cells
(lane 1), and cells irradiated in the presence (lane 2) and absence (lane 3) of AMT. PCR ampliﬁcation was performed with primers speciﬁc to domain
12. (F) RNA walk stop is conﬁrmed using speciﬁc primers. cDNA was prepared from aﬃnity selected (lanes 2 and 4) and total RNA (lanes 1 and 3)
from untreated and irradiated cells using a gene speciﬁc primer (primer LCLSUb560AS). PCR ampliﬁcation was preformed with primers speciﬁc to
domain 12.
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12  500 nucleotide domains (depicted in Figure 2B).
The results show that 4 out of the 12 domains were not
ampliﬁed by PCR, suggesting that these contain con-
tact sites between sRNA-85 and rRNA. As can be
seen, interactions between sRNA-85 and the rRNA
possibly exist in domains 2, 9, 10 and 12. The results in
Figure 2B show enrichment of rRNA that was calculated
by examining the level of the RT–PCR product produced
on aﬃnity-selected sRNA-85 with and without UV irradi-
ation. Comparison of the level of the PCR products
covering the entire rRNA suggests its higher levels in
irradiated cells. For instance 250, 900 and 480% increase
in domains 3, 6, 7, respectively was observed (Figure 2B),
demonstrating the enrichment of the rRNA target due to
its cross-linking with sRNA-85. Next, we compared the
ampliﬁcation of the four cross-linked domains to sRNA-
85 (D2, 9, 10, 12) to two non-cross-linked domains (D3,
D11). This time, the aﬃnity-selected RNA was spiked
with synthetic luciferase mRNA. cDNA was prepared,
diluted (1:500) and PCR was performed with the
domain-speciﬁc primers. The results demonstrate that
with an internal luciferase control, we could observe
major diﬀerences between the production of PCR in
cross-linked domains versus non-crossed linked domains
(Figure 2C).
To verify that the interactions discovered by the ‘RNA
walk’ method are indeed AMT cross-linking adducts, the
cross-linking was reversed in vitro, by irradiating at
254nm which reverses the cross-linking (31). The
RNA was then subjected to reverse transcription using
random primers, and the cDNA was ampliﬁed by PCR.
The results (Figure 2D) demonstrate that after reversing
the cross-linking, the rRNA from the treated cells can
be ampliﬁed by RT–PCR, suggesting that the four
unampliﬁed sites represent genuine AMT cross-linked
sites on the rRNA target. Several additional controls
were performed and the ‘stop’ was examined in cells UV
cross-linked in the absence of AMT. Under these
conditions, no stop could be observed (Figure 2E; lane
3). The stop generated by cross-linking in domain 12 can
be detected if instead of using cDNA prepared with
random primers, we prepared cDNA with a speciﬁc
primer situated in this domain (Figure 2F). However,
the use of cDNA prepared with random primer is more
useful because the same cDNA preparation can be used to
examine cross-linking at diﬀerent sites.
Next, we performed real-time PCR on cDNA prepared
from cells that were UV cross-linked or from non-cross-
linked cells. The RNA was subjected to aﬃnity selection
and the ability to amplify the rRNA was determined based
on the ampliﬁcation of the four cross-linked domains
and two non-cross linked domains (domains 3 and 12*).
The results presented in Figure 3 demonstrate that
after aﬃnity selection with sRNA-85 of RNA from the
irradiated cells it was possible to amplify domains that
are not involved in cross-linking with sRNA-85
(domains 3 and 12*). For such domains tens of
femtomoles of PCR product were generated. However,
in the same conditions only a few femtomoles of PCR
product were produced for domains cross-linked to
sRNA-85. The results demonstrate that rRNA–sRNA-85
hybrids are enriched only in samples derived from
irradiated cells. cDNA prepared from non-irradiated
cells, yielded only 1–2fmol of PCR product.
sRNA-85 mimics the mammalian SRP RNA Alu domain
in its interaction with the ribosome
In the next step, we sought to analyze the cross-linked
adducts on the rRNA target in greater detail. The
positions of the cross-linked adducts were narrowed
down by RT–PCR to domains of 100 nucleotides (data
not shown). The cross-linked adduct in domain 9 was
revealed to be in helix 95 of rRNA (SRL). The homolog
of helix 95 in trypanosome RNA is situated in srRNA-2,
which is processed from the LSU to produce an RNA
molecule of 181 nucleotides. This srRNA-2 fragment
maintains its interaction within the rRNA by base
pairing (32,33). To ﬁne map the cross-linked site
between sRNA-85 and the SRL of rRNA, we used a
primer extension assay. Reverse transcriptase, as men-
tioned above, will not pass the cross-linked adducts and
the enzyme will fall oﬀ the template one nucleotide before
the cross-linking site, creating a stop in the reaction (30).
This stop will not be seen in the RNA samples extracted
from the untreated cells. To distinguish between
intermolecular and intramolecular cross-linking, samples
of both total RNA and aﬃnity-selected sRNA-85, were
analyzed side by side. The rationale, as stated above,
is that intermolecular interactions would only be seen
in the aﬃnity-selected RNA, whereas intramolecular
interactions will be detected in both samples. In order to
ensure that the cross-linking adducts we identify are
indeed caused by AMT cross-linking, the aﬃnity-selected
sRNA-85 extracted from irradiated cells and from
untreated cells was irradiated at 254nm which reverses
the cross-linking (31). All the samples were subjected to
primer extension, and the products were separated on a
6% polyacrylamide denaturing gel alongside a DNA-
sequencing ladder of the corresponding rDNA region of
L. major. The results (presented in Figure 4A; lanes 1–6)
showed a cross-linking adduct at U68 of srRNA-2 (helix
95, the SRL domain; see Figure 4B). Note that there are
multiple stops by primer extension on total RNA, but
these were reduced in the aﬃnity-selected RNA. These
stops may stem from secondary structure, degradation
products and even intramolecular cross-links on the
target. However, after aﬃnity selection, these stops are
reduced and the speciﬁc cross-link at position U68 is
highly enriched. In all organisms (from bacteria to man)
helix 95 interacts with elongation factors EF1 and EF2
(34). Interestingly, the mammalian Alu domain interacts
with this domain. These data therefore suggest that
sRNA-85, like the mammalian Alu domain, interacts
with the SRL. The mammalian Alu domain also interacts
with helix 43. However, no evidence for cross-linking
between sRNA-85 and trypanosome helix 43 was
obtained (data not shown). Thus, either sRNA-85 does
not interact with this domain in trypanosomes or the
AMT cross-linking technique is unable to demonstrate
such an interaction. Note, pyrimidines (mostly U) have
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the AMT cross-linking technique (27).
sRNA-85 interacts with the ribosome like a tRNA molecule
The position of the second adduct on rRNA (domain 2)
was narrowed down to helix 31 of the small subunit (SSU)
rRNA, and the ﬁne mapping by primer extension is pre-
sented in Figure 5A. This cross-linking adduct at position
U1539 is a bona-ﬁde intermolecular interaction, since it is
enriched by aﬃnity selection (Figure 5A; compare lanes 2
and 4), and can be photoreversed upon irradiation at
254nm (Figure 5B; lanes 2 and 4). Interestingly, tRNA
nucleotide at position 34 was shown to interact with
helix 31 (35,36). To examine which position of sRNA-85
might interact with helix 31, the cross-linked adducts on
sRNA-85 were mapped by primer extension. The corre-
sponding position to U34 on sRNA-85 is U36, due to the
insertion of nucleotides in the anti-codon stem of this
unusual tRNA (6). Indeed, mapping of cross-linked
sites on sRNA-85 indicate a major stop at position U36
(Figure 5D), suggesting that sRNA-85 most probably
interacts with SSU U1539, possibly via its U36 position.
Note, a second stop can be observed at U34, however this
may be a structural stop since it is present in the absence
of UV (Figure 5D; lane 1). While the fact that the stop
observed on rRNA was reversed upon irradiation at
254nm (Figure 5B; lane 4), it is still possible that the
stop observed was not due to the cross-linking but
rather resulted from a post-transcriptional modiﬁcation
on the RNA present in this domain. To exclude this pos-
sibility, reverse transcription was performed under non-
optimal reaction conditions, which has been used to
map 20-O-methyls, and induces stops of the reverse
transcriptase at low dNTP concentrations (37). The
results (Figure 5F) demonstrate the presence of a modiﬁ-
cation at position 1550, since the stop one nucleotide
before the modiﬁed nucleotide was increased upon
decreasing the dNTP concentration (compare lanes 1–3;
Gm1550). The UV cross-linking at position U1539,
however, decreased (lanes 1–3; U1539) suggesting that
this nucleotide is not modiﬁed and the stop stems from
cross-linking and not modiﬁcation on this nucleotide.
Primer extension stops due to modiﬁcation or structural
stops that appear in the primer extension mapping of the
cross-link sites seem not to interfere with the ‘RNA walk’
method since only distinct stops of RT were observed with
this method.
To further demonstrate the authenticity of the cross-
linking between U36 and helix 31, we sought to examine
the cross-linked pattern of sRNA-85 lacking position
U36. We generated a mutant of sRNA-85 in which the
Figure 3. Quantitative real-time PCR analysis of the ‘RNA Walk’ method. Real-time PCR was performed as described in ‘Materials and Methods’
section using cDNA (diluted 1:100000). Concentration curves were prepared for each domain studied. The curves were used to determine the amount
of PCR product ampliﬁed from each domain. PCR was performed on DNA prepared from RNA extracted from non-irradiated cells ( UV, gray
bars) and from irradiated cells (+UV, black bars). The diﬀerent rRNA domains examined are indicated and depicted schematically underneath the
graph.
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PCR (see ‘Materials and Methods’ section) and is depicted
in Figure 6A. A cell line expressing the mutation from the
pX expression vector was generated and the expression of
the mutant was examined by northern analysis. The
results (Figure 6B) demonstrate eﬃcient expression of
the mutant compared with the wild-type RNA. Next,
the association of wild-type and mutant sRNA-85 with
the ribosome was examined. Extracts were prepared
from the transgenic cell line expressing the mutant
sRNA-85 and fractionated on a sucrose gradient. The
gradient fractions were examined by northern analysis
for the distribution of particles carrying the sRNA-85
wild-type and mutant molecules. The results (Figure 6C)
demonstrate that the mutated sRNA-85, like the wild-type
molecule, is present mainly in small RNPs (shorter
exposure) but also on ribosomes (longer exposure). The
presence of mutant sRNA-85 on the ribosomes suggests
that sRNA-85 can associate with the ribosomes even if it
cannot interact with h31 of the SSU. We next examined
the interaction of the mutant sRNA-85 with rRNA by
‘RNA walk’. Cells expressing mutant sRNA-85 were sub-
jected to UV cross-linking in the presence of AMT. RNA
isolated from the cross-linked cells was aﬃnity selected
with an anti-sense biotinylated oligonucleotide that can
speciﬁcally select only the mutant, but not the wild type,
since the primer used for selection is complementary to
positions 24–49, which includes the new junction created
by the deletion of nucleotides 36–40. Primer extension on
total RNA and aﬃnity-selected RNA showed that selec-
tion with the primer was indeed speciﬁc for the mutant
sRNA-85 (Figure 6D, compare lane 1–2). The aﬃnity-
selected RNA was then subjected to analysis using the
‘RNA walk’ method. The results (Figure 6E) demonstrate
that the stop, previously observed with wild-type sRNA-
85 in the h31 domain that interacts with the anti-codon of
sRNA-85, was eliminated. However, all the other stops
were present. This data strongly suggests that the ‘RNA
walk’ analysis is a speciﬁc and reliable method for
mapping the interaction of sRNA-85 with rRNA. The
data also suggest that sRNA-85 lacking the interaction
with h31 can still stably interact with the ribosome (see
below).
Fine mapping of the interactions with the large
subunit of rRNA
As described above for the cross-links in domains 2 and 9
(Figure 2B), we narrowed down the interaction in domain
10 to 100nt and then mapped the exact cross-linking
positions by primer extension. The interaction of sRNA-
85 in domain 10 is located at U1369 of helix 92 of the
LSUb (our unpublished results) which is part of the
PTC. The PTC is where peptide bond formation takes
place (38,39). Such an interaction may interfere with or
retard peptide bond formation.
Figure 4. sRNA-85 interacts with h95 of the SRL of rRNA. (A) Primer extension analysis to map the cross-linked sites. Cells (10
10) were treated
with AMT and irradiated with UV light at 365nm with an intensity of 10 milliWattscm
–2 for 60min. RNA was prepared from irradiated cells and
from control untreated cells and subjected to aﬃnity selection using 20-O-methyl biotinylated oligonucleotide of sRNA-85 as described in ‘Materials
and Methods’ section. Total RNA (2 mg; lane 2), 10% of the aﬃnity-selected RNA (lane 4), and 10% of the irradiated aﬃnity-selected RNA that
was further irradiated in vitro with UV at 254nm for 10min to reverse the cross-linking were prepared (lane 6). RNA from non-irradiated cells was
subjected to the same treatments (lanes 1, 3 and 5). The RNA was subjected to primer extension with radiolabeled oligonucleotide LCM2-120SRLAS
complementary to positions 119–137 of srRNA-2. Samples were separated on a 6% denaturing gel. The diﬀerent treatments are indicated above the
lanes. DNA sequencing of the srRNA-2 rDNA with the oligonucleotide used for primer extension is also shown (lanes 7–10). The sequence in the
vicinity of the cross-linked site is presented. The left arrow indicates the stop of the reverse transcriptase and the right arrow indicates the position of
the cross-linked adduct on the rRNA. (B) A portion of the secondary structure of the L. major 25S rRNA domains V and VI together with SRL
(helix 95) located in srRNA-2 is shown. The arrow indicates the position of the interaction, and the location of the primer used for primer extension
by a line.
e5 Nucleic AcidsResearch, 2010,Vol. 38,No. 1 PAGE 8 OF 15We next narrowed down the interaction domain within
domain 12 and mapped the interaction precisely. The
interaction found in domain 12 (Figure 7) is located at
U349 of helix 63 of the LSUb. This helix is not evolution-
ary conserved and its primary sequence has no known
function. Moreover, this helix is one of ﬁve helices in the
ribosome which exhibit variable lengths over evolution; in
eukaryotes it is longer than in prokaryotes (40).
Interestingly, among these ﬁve non-conserved helices,
helix 63 is the only one that cannot tolerate size
changes, suggesting it has an important role in ribosome
function (41).
Oligonucleotide/RNase H cleavage demonstrates genuine
intermolecular cross-linking between sRNA-85 and its
interaction domains on rRNA
To verify that the cross-linked species mapped by ‘RNA
walk’ and primer extension are indeed bona ﬁde
intermolecular cross-linked species between sRNA-85
and rRNA, the hybrid molecules were conﬁrmed by
RNase H mapping. To map the interaction between
these molecules sRNA-85 and its associated rRNA were
tagged by the splint labeling technique. In this method, a
primer complementary to sRNA-85 carrying a run of 9 G
Figure 5. The sRNA-85 interaction with helix 31 of SSU is a canonical tRNA interaction in the P site. (A) Cells (10
10) were treated with AMT and
irradiated with UV light at 365nm with an intensity of 10milliWattscm
–2 for 60min. RNA was prepared from irradiated cells and from control
untreated cells and subjected to aﬃnity selection using a 2’-O-methyl biotinylated oligonucleotide of sRNA-85 as described in ‘Materials and
Methods’ section. Total RNA (2mg; lanes 1 and 2) or 10% of the aﬃnity-selected RNA (lanes 3 and 4) from untreated and irradiated cells was
subjected to primer extension with the oligonucleotide indicated schematically in (C). The products were separated on a 6% polyacrylamide
denaturing gel alongside a DNA-sequencing ladder (lanes 5–8) of the corresponding SSU rDNA. The sequence in the vicinity of the cross-linked
site is indicated. The left arrow indicates the stop of the reverse transcriptase and the right arrow indicates the position of the cross-linked adducto n
the rRNA. (B)A si n( A), but the cross-linking was reversed by UV irradiation at 245nm (10milliWattscm
 2) for 10min. Aﬃnity-selected RNA
(10% of total; lanes 1 and 2) and the same amount of RNA that was subjected to photoreversal cross-linking (lanes 3 and 4) was analyzed by primer
extension as described in (A). The treatments are indicated and the arrow marks the cross-linked adducts on the rRNA. (C) A portion of the
secondary structure of the L. major SSU rRNA is shown. The cross-linked site of SSU helix 31 is indicated by an arrow and the location of the
oligonucleotide primer used for primer extension by a line. (D)A si n( A), but samples were subjected to primer extension using oligonucleotide 18490
complementary to positions 39–53 of sRNA-85 (lanes 1 and 2). RNA sequencing of sRNA-85 is shown (lanes 3–6). The left arrow indicates the stop
of the reverse transcriptase and the right arrow indicates the position of the cross-linked adduct on sRNA-85. (E) Secondary structure of sRNA-85.
Arrows indicate the two cross-linked sites on the RNA. (F) RNA isolated from irradiated cells was subjected to aﬃnity selection and primer
extension was preformed as in (A) except that a gradient of dNTP concentration (0.05, 0.5 and 5 mM dNTPs; lanes 1–3, respectively) was used. The
products were separated on a 6% polyacrylamide denaturing gel. The arrows on the right indicate the cross-link site identiﬁed in (A) as well the
modiﬁed Gm1550, the stops are one nucleotide before the cross-linked or modiﬁed site.
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as a template to incorporate [a-
32P]-dCTP at the 30-end of
the sRNA-85 using the enzyme T7 DNA polymerase. In
such an experiment we anticipate to identity cross-linking
species between sRNA-85 and the diﬀerent rRNA species
(srRNA-2, LSU and SSU). To be able to detect such
cross-linking in a denaturing gel that separates molecules
in the size range of ten to hundreds of nucleotides, it is
necessary to ‘release’ the rRNA domain that is cross-
linked to sRNA-85. Indeed, we can observe that after
cross-linking and labeling the cross-linked species, large
amount of the label was trapped at the top of the gel
and was unable to enter it. To release the cross-linked
adducts, the cross-linked species were digested with
RNase H and oligonucleotides ﬂanking the predicted
cross-linked sites. Next, these fragments were labeled by
splint labeling of sRNA-85. This labeling should detect
free sRNA-85 present in the sample and the rRNA
fragments linked to this molecule. In addition and as
previously demonstrated (6), the sample should also
contain the 7SL RNA-sRNA-85 cross-links. The results
of such experiments are presented in Figure 8. A fragment
common to lanes 2–7 (marked with an arrow) represent
two co-migrating fragments, 7SL RNA-sRNA-85 and
Figure 6. ‘RNA walk’ of mutant sRNA-85 lacking the anti-codon loop. (A) Schematic representation of deletion mutation introduced in the sRNA-
85. The deletion is indicated by a box. (B) Northern analysis of cells carrying the sRNA-85 mutation. The blot was probed with anti-sense
oligonucleotide (18288), speciﬁc to sRNA-85 that recognizes both wild-type and mutant transcripts. (C) Distribution of wild-type and mutant
sRNA-85 on RNP particles. Low-salt extracts from cells carrying the mutation in sRNA-85 were layered on continuous 10–30% sucrose gradients
containing 100mM KCl. Gradients were centrifuged for 3h at 35000 rpm using SW41 rotor, as described in ‘Materials and Methods’ section. RNA
prepared from the sucrose gradient fractions was subjected to northern analysis and the blot was hybridized with the same probe as in (B). S values
were determined using standards, i.e. 30, 50 and 70 ribosomes from E. coli and enzyme catalase (10S). The fractions are numbered from top to
bottom. The positions of the wild-type and mutated RNA are indicated. Upper panel$long exposure, Lower panel$short exposure. (D) Aﬃnity
selection of mutant sRNA-85. RNA was prepared from irradiated cells expressing the sRNA-85 mutant as described previously. The RNA (from
10
10 cells) was subjected to aﬃnity selection as described in ‘Materials and Methods’ section. RNA from aﬃnity selected and from total RNA was
subjected to primer extension and the products were separated on a 6% polyacrylamide denaturing gel. (E) ‘RNA walk’ analysis of sRNA-85
mutant. RNA was prepared from irradiated cells and from control untreated cells expressing the sRNA-85 mutant as described in Figures 1–3. The
RNA (from 10
10 cells) was subjected to aﬃnity selection as described in ‘Materials and Methods’ section. The aﬃnity-selected product was subjected
to reverse transcription using random primers. The cDNA was ampliﬁed by PCR using the primer pairs shown. The PCR products were separated
on 1.5% agarose gel and detected by ethidium bromide staining. RNA from irradiated and untreated cells is designated by (+) and ( ), respectively.
The positions of the PCR domains are marked by double-headed arrows on the rRNA subunits (indicated). Stars mark the domains carrying the
cross-linked adducts.
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either srRNA-2 (lane 4) or 7SL RNA (lane 7)
oligonucleotides reduced the intensity of this fragment
and produced new fragments (number 2 and 5) for
srRNA-2 and 7SL RNA, respectively, suggesting that
this fragment is composed of these two cross-linked
species. Furthermore, the cleavage with rRNA-speciﬁc
oligonucleotide ﬂanking the cross-linked species released
diﬀerent size fragments; fragments number 1, 3 and 4. The
size of these fragments was larger than the distance
between the oligonucleotides used for digestion (marked
in Figure 8B) because of the cross-linking to sRNA-85,
which causes aberrant mobility of the cross-linked
hybrid molecule in denaturing gels. To further verify
that indeed these fragments were cleaved from their
expected positions in the rRNA, the cleaved-labeled
fragments were eluted from the gel and were further sub-
jected to cleavage with an oligonucleotide situated
between the cross-linked position and the 30-end of the
fragment (see Figure 8C and D, and data not shown).
The results (Figure 8C) demonstrate such cleavage of the
fragment derived from the SRL (srRNA-2), number 2
(lane 1) using oligonucleotide D (lane 2). As a control,
the fragment was cleaved with an oligonucleotide E
situated outside this domain (lane 3). The cleavage of
the fragment derived from the h63 domain (fragment
number 4) is presented in Figure 8D. Speciﬁc cleavage
was observed only when the oligonucleotide situated in
between the 30-end of the fragment (oligonucleotide J)
and the cross-linked nucleotide (lane 2) was used, but
not when an oligonucleotide situated downstream of the
30 end of the fragment (oligonucleotide K) was used (lane
3). These data clearly demonstrate that the cross-linked
sites represent an intermolecular linkage between sRNA-
85 and the diﬀerent sites on the rRNA.
To investigate if the four contact sites of sRNA-85 may
represent interactions that can take place simultaneously,
or whether these interactions may require the movement
of this molecule within the ribosome, we sought to obtain
structural information that will enable us to locate the
interactions within the tertiary structure of the ribosome.
Since there is no available crystal structure of eukaryotic
ribosomes but only cryo-EM data of the yeast ribosome
(35), we based our mapping on the crystal structure of the
Thermus thermophilus 70S ribosome (PDB ﬁles 2J00 and
2J01) (42). To spatially locate the various cross-linked
sites within the ribosome, we matched the rRNA
sequence of L. collosoma (L.c) rRNA and their corre-
sponding sites in T. thermophilus. Our analysis indicates
that there is only one possible way to position a tRNA
into the ribosome that agrees well with three of the contact
sites. To construct our model, we used a tRNA
Phe which is
76 nucleotides long to simulate the interaction. Note that
sRNA-85 is longer (85 nucleotides) and hence the
proposed distances based on tRNA
Phe might be slightly
diﬀerent. Modeling tRNA
Phe suggests distances of  11A ˚
with the Alu-like domain (helix 95),  12.5A ˚ with the PTC
(helix 92) and  11A ˚ with the SSU of the rRNA (helix 31)
(data not shown). Note, that the universal tRNA interac-
tion with the SSU in helix 31 mapped in Figure 5 helped us
to determine the orientation of the molecule within the
ribosome. The interaction with A1745 (helix 63) seems
Figure 7. Mapping the contact site of sRNA-85 in h63 of LSU. Cells (5 10
9) were irradiated with UV at 365nm with an intensity of
10milliWattscm
–2 for 60min in the presence of AMT. RNA was prepared from irradiated cells and from control untreated cells and subjected
to aﬃnity selection using 20-O-methyl biotinylated oligonucleotide of sRNA-85 as described in ‘Materials and Methods’ section. Total RNA (lanes
1–2), aﬃnity-selected RNA (lanes 3–4) and aﬃnity-selected RNA after photoreversal (lanes 5–6) was subjected to primer extension with the
radiolabeled oligonucleotide indicated in the secondary structure map on the right. The products were separated on a 6% polyacrylamide denaturing
gel alongside a DNA-sequencing ladder of the corresponding LSUb rDNA (lanes 7–10). The sequence in the vicinity of the cross-linked site is
indicated. The left arrow indicates the stop site of the reverse transcriptase and the right arrow indicates the position of the cross-linked adduct on
the rRNA. The position of the cross-linked site is circled and indicated with an arrow and the primer used by a line on the secondary structure map.
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(helices 31, 92, 95) to allow its concomitant interaction.
Thus, it is possible that this interaction reﬂects another
conformation of sRNA-85 within the ribosome. The
model further demonstrates that sRNA-85 occupies the
interspace between the two ribosomal subunits and
suggests that sRNA-85 may move during the
translocation cycle.
DISCUSSION
In this study, we present a novel approach to identify
RNA–RNA interactions between a small RNA and a
complex target, the entire rRNA. Our approach is based
on in vivo UV cross-linking in the presence of AMT.
Enrichment of the target via aﬃnity selection of the
small RNA enables the use of RT–PCR to map
interactions even with a target as large as the entire
rRNA. This novel approach enabled us to map the
interactions between the tRNA-like RNA of the
trypanosome SRP, and the ribosome. The mapping
identiﬁed four cross-linked sites that were veriﬁed by
primer extension and oligonucleotide/RNase H cleavage.
Three of the cross-linked sites are located in domains of
known functions. Most intriguing is the ﬁnding that
sRNA-85 interacts with helix 95, the SRL, an interaction
analogous to the mammalian Alu domain; this suggests
molecular mimicry between sRNA-85 and the mammalian
Alu domain. Interestingly, a contact site was also found
with the PTC. These contact sites with the SRL and the
PTC may suggest that this novel tRNA can transiently
block translation. The strength of the ‘RNA walk’
method is that it is performed in vivo and therefore can
capture interactions which are transient and often weak.
The methodology is simple, quantitative and aﬀords
quick scanning of a large target for the binding sites
of small RNAs. The method was used in this study to
elucidate a complex interaction in trypanosomes, but
it should be applicable to any biological system from
bacteria to man.
Figure 8. RNAse H mapping of sRNA-85-rRNA cross-linked species. (A) Aﬃnity-selected RNA from untreated (lane 1) and irradiated (lanes 2–7)
cells were hybridized with diﬀerent primers, spanning the regions identiﬁed as adducts by RNA walk, as well as 7SL RNA as indicated on top of
each lane, and cleaved with RNAse H. The sRNA-85 was then speciﬁcally labeled by splint labeling (see ‘Materials and Methods’ section), and the
products were separated on a 6% polyacrylamide denaturing gel. The ‘free’ sRNA-85, the sRNA-85-7SL RNA and the sRNA-85-srRNA-2 cross-
linked species are marked by arrows. The cross-linked species released by the RNAse H cleavage are marked by numbers. (B) Schematic map of the
rRNAs showing the location of cross-linked adducts (marked by numbers), the location of the primers used for RNAse H cleavage and the distance
between the primers. The primers are listed in Table S1. (C) The RNase H cleavage of fragments carrying the cross-linked adducts. Cross-linked
species derived from cleavage with rRNA oligonucleotides were gel puriﬁed and further digested by oligonucleotide/RNAse H. Cross-linked species
derived by cleavage with oligonucleotide C (lane 1) was digested with oligonucleotide D (lane 2) or oligonucleotide E (lane 3). (D) Cross-linked
species derived by cleavage with oligonucleotide H (lane 1) was cleaved either oligonucleotide J (lane 2) or oligonucleotide K (lane 3). The fragment
carrying the cross-linked adduct is marked with an arrow and the cleavage product derived with an asterisk. (E) Schematic map of the rRNAs
showing the location of the primers used for RNase H cleavage in C and D.
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implications on attenuating protein synthesis
The trypanosome 7SL RNA lacks the Alu domain L1.2
loop as well as the Alu domain-binding proteins, SRP9
and 14 (7,22). This raises the question of how such an
SRP, lacking a functional Alu domain, can mediate a
translation pause. sRNA-85 may represent an elegant
solution for the arrest function by interacting with two
functional domains of the ribosome, which aﬀect transla-
tion, the binding site of the elongation factors (SRL) and
the PTC. The SRL binds to elongation factors EF1 and
EF2, which are required for eﬃcient and accurate trans-
lation (43,44). Astonishingly, the sRNA-85 interaction
with h95 (SRL), is identical to one of the contacts of the
mammalian Alu domain with the ribosome (18). sRNA-85
may therefore represent a molecular mimic of the mam-
malian Alu domain and mediate the translational arrest
function of trypanosome SRP. However, the actual arrest
may involve a trypanosome-speciﬁc mechanism that may
elicit an even stronger eﬀect on the translating ribosome.
Indeed, sRNA-85 was shown to interact with the PTC,
where peptide bond formation is carried out. The interac-
tion of sRNA-85 with the PTC seems to be unique. The
binding sites of tRNA located in the A site or P site and
the PTC site are well documented. C74 and C75 of the
P-site tRNA base pair to G2252 and G2251, respectively
of the 23S rRNA (45). The CCA end of the A-site tRNA is
ﬁxed by pairing of C75 with G2553 of the 23S A-loop
(46,47). The contact site of sRNA-85 with the PTC is dif-
ferent from these interactions and is located at h92
(position 2561). Recent, comprehensive genetic studies of
functional domains within the PTC showed that position
2573 (adjacent to the cross-linked site- position 2561)
plays a role in guiding the rotating tRNA from the A to
the P site. In addition, h92 interacts with h71 (domain IV)
of rRNA (48,49) and a mutation in C2556 (also close to
the sRNA-85 cross-linked site) induces steric hindrance,
which disrupts the interaction between h92 and h71, also
aﬀecting the function of the ribosome (50). Thus, the
pause in translation that the trypanosome SRP may
elicit on the translating ribosome might be even stronger
than that induced by the mammalian SRP.
The interaction of sRNA-85 with helix 31 in the SSU is
a conventional tRNA interaction which places the tRNA
anti-codon stem loop in the small subunit and allows the
CCA end of the molecule to interact with the large
subunit. Note, however that three out of the four
contact sites mapped in this study are non-canonical
tRNA interactions. In addition, 14 canonical tRNA
interactions with the ribosome could not be detected
between sRNA-85 and rRNA (data not shown). Our
inability to detect these cross-linked sites may stem from
the limitations of the method, as discussed above.
However, these results may also reﬂect the inability of
sRNA-85 to interact with conventional sites due to its
deviations from the canonical structure; sRNA-85 is
uncharged, and has a longer anti-codon stem with
several bulges (6). These deviations may have caused the
loss of the conventional interactions and helped this
molecule to acquire special interactions necessary to
fulﬁll its function in translation arrest. Interestingly,
deletion of the anti-codon of sRNA-85 eliminated its
ability to interact with h31, yet sRNA-85 can still
interact with the ribosome via the other binding sites
(Figure 6).
Our previous studies suggest that sRNA-85 interacts
with the 7SL RNA by base pairing between positions 26
and 42 of the 7SL RNA (truncated Alu domain) and the
sRNA-85 molecule (positions 15–30) (6). Can sRNA-85
interact simultaneously with 7SL RNA and the
ribosome? The interactions of sRNA-85 with the LSU
are predicted to occur at the 30-end of the tRNA. The
four interactions of sRNA-85 with the rRNA, however,
are not mutually exclusive to the interactions of 7SL RNA
with sRNA-85, since the latter interactions were mapped
to the 5’ end of the molecule. We therefore propose that
sRNA-85 potentially interacts with the 7SL RNA
throughout the translocation cycle.
Using the cross-linking positions of sRNA-85 and
rRNA, we made attempts to position a known tRNA
crystal to the crystal of eubacterial crystal structure
(PDB ﬁle 2J01), Although the model is speculative, it
suggests that while the interactions of sRNA-85 with the
SSU, the PTC, and the SRL domains can take place
simultaneously, the interaction of sRNA-85 with h63 is
too far away from the triangle interactions. If indeed
h63 is located far from the triangle interaction, the inter-
action with this domain may require other conformational
changes of this molecule within the ribosome. sRNA-85
might have at least two conformations within the
ribosome, the functional binding to the PTC and SRL
(the triangle interaction) and another conformation
which predominates either before or after the triangle
functional interaction.
Pros and cons of the ‘RNA walk’ approach
‘RNA walk’ can be viewed as a generic method to map the
interaction sites between a small RNA and its target, even
with a target as large as the entire rRNA. The method is
reliable only after enrichment of the cross-linked species
by aﬃnity selection with the small RNA as a ‘hook’. The
aﬃnity selection is very critical step for the ‘RNA walk’
method. Only the selection of hybrid molecules enable the
enrichment of speciﬁc rRNA molecules that were bound
by sRNA-85, avoiding RT–PCR stops emerging from
intermolecular cross-linking.
Statistically, at the level of irradiation used in this study
each molecule will be cross-linked only once. However,
since there are potentially four sites of cross-linking, the
aﬃnity-selected RNA should contain molecules that were
not cross-linked at the tested cross-linked domain. Indeed,
we were unable to eﬃciently amplify rRNA using primers
spanning each of the cross-linked sites.
One of the drawbacks of the ‘RNA walk’ method is the
eﬃciency of capturing the molecules that can teach us
about the RNA–RNA interactions. The eﬃciency of selec-
tion can vary considerably for diﬀerent small RNAs (in
this study only 20% of sRNA-85 was selected). In some
cases, it will not be possible to use the small RNA as the
hook for aﬃnity selection, like in the case of the miRNA
PAGE 13 OF 15 Nucleic AcidsResearch, 2010,Vol. 38,No. 1 e5that is only 21-nt long, and part might be involved in
cross-linking to the target. In such cases, the aﬃnity selec-
tion should be mediated via the target.
The low abundance of the hybrid molecules could make
it diﬃcult to detect RNA–RNA interactions by the ‘RNA
walk’. The interaction examined in this study is between
rRNA that is found at 200000 copies per cell and sRNA-
85 that is  100-fold less abundant. If on the other hand,
mRNAs are considered as the target, the ability to capture
hybrid molecules may be reduced by up to  1000-fold.
However, it should be possible to detect the interaction
between mRNA and a small RNA that interacts with it
using larger quantities of cDNA. The authenticity of
‘RNA walk’ has been demonstrated by showing that the
adducts revealed by this method were conﬁrmed by both
primer extension and RNase H cleavage mapping.
However, there might be additional contact sites that the
‘RNA walk’ failed to identify because the AMT cross-
linking is limited to U which are in close proximity
within the interaction domain, although Cs were also
shown to be cross-linked (27).
In summary, this study describes the ‘RNA walk’, a
generic method to identify small RNA target interactions
based on in vivo cross-linking with AMT, aﬃnity selection
of the target and mapping the adducts by a variety of
techniques. This method led to identiﬁcation of novel
interaction sites that could not be guessed by modeling
or predicted bioinformatically. The method was used to
probe the interaction between a unique and novel tRNA-
like molecule in trypanosomes, sRNA-85 and the entire
rRNA. The study led to discovery of molecular mimicry
between this novel molecule and the Alu domain of the
mammalian SRP. This study therefore suggests that
several diﬀerent solutions might exist in nature to fulﬁll
the arrest function of the SRP; such possible mechanisms
should be particularly investigated in bacteria and in lower
eukaryotes whose SRP lacks the Alu domain. ‘RNA walk’
is a simple, quick and quantitative method that can be
used to examine RNA–RNA interactions between a
small RNA and its target being rRNA or less abundant
mRNA. Each pair of interactions will need a special cal-
ibration to ﬁnd the optimal target for aﬃnity selecting the
hybrid small RNA with its target.
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